Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid-based antisense: A potential new drug candidate for pancreatic cancer.

Shai, Ayelet; Galouk, Evleen; Miari, Reem; Tareef, Hala; Sammar, Marei; Zeidan, Mouhammad; Rayan, Anwar; Falah, Mizied.

Afiliação

Shai A; Oncology Department, Galilee Medical Center, Nahariya 2210001, Israel.
Galouk E; Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
Miari R; Oncology Department, Galilee Medical Center, Nahariya 2210001, Israel.
Tareef H; Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
Sammar M; Oncology Department, Galilee Medical Center, Nahariya 2210001, Israel.
Zeidan M; Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
Rayan A; Oncology Department, Galilee Medical Center, Nahariya 2210001, Israel.
Falah M; Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.

Oncol Lett ; 23(4): 130, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35251350